ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 65 filers reported holding ATRECA INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,479 | -73.4% | 105,283 | 0.0% | 0.00% | – |
| Q2 2023 | $103,177 | -14.0% | 105,283 | 0.0% | 0.00% | – |
| Q1 2023 | $120,023 | +42.4% | 105,283 | 0.0% | 0.00% | – |
| Q4 2022 | $84,290 | -63.0% | 105,283 | -27.5% | 0.00% | -100.0% |
| Q3 2022 | $228,000 | -12.3% | 145,166 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $260,000 | -43.5% | 145,166 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $460,000 | -88.3% | 145,166 | -76.9% | 0.00% | -87.5% |
| Q3 2021 | $3,916,000 | -26.9% | 628,536 | 0.0% | 0.01% | -27.3% |
| Q2 2021 | $5,355,000 | -43.6% | 628,536 | +1.6% | 0.01% | -45.0% |
| Q1 2021 | $9,487,000 | +390.0% | 618,880 | +416.1% | 0.02% | +400.0% |
| Q4 2020 | $1,936,000 | +81.1% | 119,916 | +56.7% | 0.00% | +33.3% |
| Q3 2020 | $1,069,000 | +304.9% | 76,549 | +517.3% | 0.00% | +200.0% |
| Q2 2020 | $264,000 | – | 12,401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,320,880 | $2,100,000 | 1.66% |
| CM Management, LLC | 249,282 | $391,000 | 0.44% |
| Aisling Capital Management LP | 387,653 | $609,000 | 0.40% |
| Boxer Capital, LLC | 2,202,333 | $3,458,000 | 0.19% |
| Samsara BioCapital, LLC | 396,835 | $623,000 | 0.14% |
| Redmile Group, LLC | 800,306 | $1,256,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 191,442 | $301,000 | 0.04% |
| Baker Brothers Advisors | 3,532,760 | $5,546,000 | 0.04% |
| Cormorant Asset Management, LP | 319,057 | $501,000 | 0.04% |
| Rock Springs Capital Management LP | 462,530 | $726,000 | 0.02% |